Anticancer therapy-induced adverse events: Practicing damage control Journal Article
| Authors: | Lacouture, M. E.; Lenihan, D.; Wu, S. |
| Article Title: | Anticancer therapy-induced adverse events: Practicing damage control |
| Keywords: | cancer chemotherapy; overall survival; review; bevacizumab; cisplatin; doxorubicin; cancer growth; diarrhea; drug efficacy; drug safety; colorectal cancer; metastasis; progression free survival; breast cancer; bleeding; lung non small cell cancer; cetuximab; panitumumab; hypomagnesemia; health care cost; head and neck cancer; cardiotoxicity; glioblastoma; oxidative stress; intestine perforation; maximum tolerated dose; taxane derivative; kidney cancer; anthracycline; transitional cell carcinoma; therapy; vinflunine; heart injury; adverse events; razoxane; carvedilol; phase 4 clinical trial (topic) |
| Journal Title: | Expert Opinion on Drug Safety |
| Volume: | 11 |
| Issue: | Suppl. 1 |
| ISSN: | 1474-0338 |
| Publisher: | Informa Healthcare |
| Date Published: | 2012-05-01 |
| Start Page: | S1 |
| End Page: | S3 |
| Language: | English |
| DOI: | 10.1517/14740338.2012.669371 |
| PROVIDER: | scopus |
| PUBMED: | 22409299 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 2 April 2012" - "CODEN: EODSA" - "Source: Scopus" |
